Skip to main content
Top
Published in: Virchows Archiv 4/2012

Open Access 01-10-2012 | Original Article

Tumor architecture exerts no bias on nuclear grading in breast cancer diagnosis

Authors: Braulio Mora, Dario Bombari, Stephan C. Schaefer, Marcus Schmidt, Jean-Francois Delaloye, Fred Mast, Hans-Anton Lehr

Published in: Virchows Archiv | Issue 4/2012

Login to get access

Abstract

We recently reported that nuclear grading in prostate cancer is subject to a strong confirmation bias induced by the tumor architecture. We now wondered whether a similar bias governs nuclear grading in breast carcinoma. An unannounced test was performed at a pathology conference. Pathologists were asked to grade nuclei in a PowerPoint presentation. Circular high power fields of 27 invasive ductal carcinomas were shown, superimposed over low power background images of either tubule-rich or tubule-poor carcinomas. We found (a) that diagnostic reproducibility of nuclear grades was poor to moderate (weighed kappa values between 0.07 and 0.54, 27 cases, 44 graders), but (b) that nuclear grades were not affected by the tumor architecture. We speculate that the categorized grading in breast cancer, separating tubule formation, nuclear pleomorphism, and mitotic figure counts in a combined three tier score, prevents the bias that architecture exerts on nuclear grades in less well-controlled situations.
Literature
1.
go back to reference Cattoretti G, Becker MH, Key G et al (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363PubMedCrossRef Cattoretti G, Becker MH, Key G et al (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363PubMedCrossRef
2.
go back to reference Schmidt M, Hellwig B, Hammad S et al (2012) A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res 18:2695–2703PubMedCrossRef Schmidt M, Hellwig B, Hammad S et al (2012) A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res 18:2695–2703PubMedCrossRef
3.
go back to reference Kelly CM, Bernard PS, Krishnamurthy S et al (2012) Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer. Oncologist 17:492–498PubMedCrossRef Kelly CM, Bernard PS, Krishnamurthy S et al (2012) Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer. Oncologist 17:492–498PubMedCrossRef
4.
go back to reference Schmidt M, Böhm D, von Törne C et al (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68:5405–5413PubMedCrossRef Schmidt M, Böhm D, von Törne C et al (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68:5405–5413PubMedCrossRef
5.
go back to reference Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359–377PubMedCrossRef Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359–377PubMedCrossRef
6.
go back to reference Elston EW, Ellis IO (1993) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403–410CrossRef Elston EW, Ellis IO (1993) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403–410CrossRef
7.
go back to reference Fandel TM, Pfnür M, Schäfer SC et al (2008) Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol 216:193–200PubMedCrossRef Fandel TM, Pfnür M, Schäfer SC et al (2008) Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol 216:193–200PubMedCrossRef
8.
go back to reference Bombari D, Mora B, Schaefer SC, Mast F, Lehr HA (2012) What was I thinking? Eyetracking experiments underscore the bias that architecture exerts on nuclear grading in prostate cancer grading. PLoS ONE 7:e38023PubMedCrossRef Bombari D, Mora B, Schaefer SC, Mast F, Lehr HA (2012) What was I thinking? Eyetracking experiments underscore the bias that architecture exerts on nuclear grading in prostate cancer grading. PLoS ONE 7:e38023PubMedCrossRef
10.
go back to reference Frierson HF Jr, Wolber RA, Berean KW et al (1995) Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198PubMed Frierson HF Jr, Wolber RA, Berean KW et al (1995) Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198PubMed
11.
go back to reference Sikka M, Agarwal S, Bhatia A (1999) Interobserver agreement of the Nottingham histologic grading scheme for infiltrating duct carcinoma breast. Indian J Cancer 36:149–153PubMed Sikka M, Agarwal S, Bhatia A (1999) Interobserver agreement of the Nottingham histologic grading scheme for infiltrating duct carcinoma breast. Indian J Cancer 36:149–153PubMed
12.
go back to reference Meyer JS, Alvarez C, Milikowski C, Olson N et al (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 18:1067–1078PubMedCrossRef Meyer JS, Alvarez C, Milikowski C, Olson N et al (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 18:1067–1078PubMedCrossRef
Metadata
Title
Tumor architecture exerts no bias on nuclear grading in breast cancer diagnosis
Authors
Braulio Mora
Dario Bombari
Stephan C. Schaefer
Marcus Schmidt
Jean-Francois Delaloye
Fred Mast
Hans-Anton Lehr
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 4/2012
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-012-1304-1

Other articles of this Issue 4/2012

Virchows Archiv 4/2012 Go to the issue